MSB 10.4% $1.49 mesoblast limited

Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-80

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 457 Posts.
    lightbulb Created with Sketch. 265
    STOP JUMPING AT SHADOWS. They can only use MSCs if they have tried all alternative therapy options.
    It does not mean there are no alternative therapy options.

    What don't people understand about a double blind trial? No-one knows until it is unblinded, not even the FDA, not even the doctors, NO-ONE.
    There is not someone tallying results as they come in then conveying this to some central body - this is not a double blind trial. They will only release the results of the first 90 once the first 90 have completed the trial. Then the results can be tallied. This will not happen overnight.
    If half the people have died, how do the doctors know that it is controls and not the MSC patients. They don't. Therefore they cannot 'know' the treatment is working.

    FDA are basing judgement on the small test cases with COVID and cases with aGVHD. Things are grim so they are willing to allow use of unapproved treatments under strict control - only when all approved treatments have been used and proved ineffective.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.